April 5-6, 2025 | Nashville

Accreditation

Intended Learners 

This educational activity is specifically designed for gastroenterologists, hospitalists, internal medicine specialists, and other healthcare professionals (physicians in training, nurses, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with IBD. 

Learning Objectives

After completing this activity, participants should be able to:

  • Describe the current understanding of IBD pathophysiology with respect to inflammatory signaling pathways and potential therapeutic targets
  • Integrate clinical evidence, recent real-world data, current guidelines, and patient preferences into individualized treatment plans for IBD patients
  • Assess the mechanism of action and therapeutic potential of evolving treatments in IBD
  • Interpret clinical data for integration into the management of special patient populations in IBD

Accreditation Statement

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.

Provider Statement

Provided by HMP Education, an HMP Global Company.

Back to top